Neuromyelitis optica and Asian phenotype of multiple sclerosis

Annals of the New York Academy of Sciences

Volumn 1142, Issue , 2008, Pages 58-71

  Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aquaporin 4; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ASIAN; AUTOIMMUNITY; BRAIN DAMAGE; CLINICAL FEATURE; DISEASE CLASSIFICATION; HISTORY OF MEDICINE; HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELOOPTIC NEUROPATHY; NERVE FIBER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PATHOGENESIS; PHENOTYPE; RACE DIFFERENCE; RELAPSE; REVIEW; SPINAL CORD; SPINAL CORD LESION;

EID: 54949094681     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1444.002     Document Type: Review

References (61)

1. Kira, J. 2003. Multiple sclerosis in the Japanese population. Lancet Neurol. 2 : 117 127.
2. Lennon, V.A. et al. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 : 2106 2112.
3. Nakashima, I. et al. 2006. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatry 77 : 1073 1075.
4. Weinshenker, B.G. et al. 2006a. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol. 5 : 110 111.
5. Dević, E. 1894. Myélite subaiguë compliquée de névrite optique-Autopsie. Congrés Francais de Médecine 1 : 434 439.
6. Beck, G.M. 1927. Diffuse myelitis with optic neuritis. Brain 50 : 687 703.
7. Balser, B.H. 1936. Neuromyelitis optica. Brain 59 : 353 365.
8. Stansbury, F.C. 1949. Neuromyelitis optica (Devic's disease); presentation of five cases, with pathologic study, and review of literature. Arch. Ophthalmol. 42 : 292 335.
9. Okinaka, S. et al. 1958. Multiple sclerosis and allied diseases in Japan; clinical characteristics. Neurology 8 : 756 763.
10. Kuroiwa, Y. et al. 1975. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 25 : 845 851.
11. Shibasaki, H. et al. 1981. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J. Neurol. Sci. 49 : 253 271.
12. Kira, J. et al. 1996. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40 : 569 574.
13. Yamasaki, K. et al. 1999. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122 : 1689 1696.
14. Ochi, H. et al. 2001. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J. Neuroimmunol. 119 : 297 305.
15. Wu, X.M. et al. 2000. Flow cytometric differentiation of Asian and Western types of multiple sclerosis (MS), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J. Neurol. Sci. 177 : 24 31.
16. Hung, T.-P. et al. 1976. Multiple sclerosis amongst Chinese in Taiwan. J. Neurol. Sci. 27 : 459 484.
17. Tabira, T. et al. 1982. Neuropathological features of MS in Japan. In Multiple Sclerosis East and West. Y. Kuroiwa & L.T. Kurland, Eds 273 295. Fukuoka. Kyushu University Press.
18. Ikuta, F. et al. 1982. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. In Multiple Sclerosis East and West. Y. Kuroiwa & L.T. Kurland, Eds 297 306. Fukuoka. Kyushu University Press.
19. Lucchinetti, C.F. et al. 2002. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 : 1450 1461.
20. Ishizu, T. et al. 2005. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128 : 988 1002.
21. Wingerchuk, D.M. et al. 1999. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 : 1107 1114.
22. Tartaglino, L.M. et al. 1995. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195 : 725 732.
23. Bot, J.C.J. et al. 2004. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62 : 226 233.
24. Chong, H.T. et al. 2004. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Neurol. Asia 9 : 47 53.
25. Minohara, M. et al. 2006. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J. Neuroimmunol. 178 : 156 160.
26. Su, J.J. et al. 2006. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J. Neurol. Sci. 243 : 21 30.
27. Matsuoka, T. et al. 2008. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J. Neurol. Sci. 266 : 115 125.
28. Barkhof, F. et al. 1997. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 : 2059 2069.
29. Polman C.H., et al. 2005. Multiple sclerosis diagnostic criteria: three years later. Mult. Scler. 11 : 5 12.
30. Matsushita, T. et al. 2008. Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study. Mult. Scler. 14 : 343 353.
31. Poser, C.M. et al. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 : 227 231.
32. Fukazawa, T. et al. 2000. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55 : 199 205.
33. Matsuoka, T. et al. 2008. Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Mult. Scler. In press.
34. Lennon, V.A. et al. 2005. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202 : 473 477.
35. Matsuoka, T. et al. 2007. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130 : 1206 1223.
36. Pittock, S.J. et al. 2006. Brain abnormalities in neuromyelitis optica. Arch. Neurol. 63 : 390 396.
37. Wingerchuk, D.M. et al. 2006. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 : 1485 1489.
38. Pittock, S.J. et al. 2006. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol. 63 : 964 968.
39. Jarius, S. et al. 2007. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68 : 1076 1077.
40. Paul, F. et al. 2007. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 4 : e133.
41. Takahashi, T. et al. 2007. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130 : 1235 1243.
42. Tanaka, K. et al. 2007. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult. Scler. 13 : 850 855.
43. Osoegawa, M. et al. 2007. Temporal and geographical changes of multiple sclerosis phenotype in Japanese: nationwide survey results over 30 years. 23rd Congress of the ECTRIMS. Mult. Scler. 13 : S101.
44. Wingerchuk, D.M. et al. 2007. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 68 : 603 605.
45. Saida, T. et al. 2005. Interferon beta-1b is effective in Japanese RRMS patients. A randomized, multicenter study. Neurology 64 : 621 630.
46. Misu, T. et al. 2007. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130 : 1224 1234.
47. Roemer, S.F. et al. 2007. Pattern-specific loss of aqaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 : 1194 1205.
48. Weinshenker, B.G. et al. 2006. Neuromyelitis optica IgG predicts relapse after longitudinally extensive myelitis. Ann. Neurol. 59 : 566 569.
49. Mathey, E.K. et al. 2007. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 204 : 2363 2372.
50. Collongues, N. et al. 2007. Devic's neuromyelitis optica MOG-induced in rat Brown Norway is associated with ant-AQP4 antibodies. 23rd Congress of the ECTRIMS. Mult. Scler. 13 : S259.
51. Wingerchuk, D.M. et al. 2007. The spectrum of neuromyelitis optica. Lancet Neurol. 6 : 805 815.
52. Jarius, S. et al. 2007. Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis. 23rd Congress of the ECTRIMS. Mult. Scler. 13 : S159.
53. Weaver, C.T. et al. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25 : 821 852.
54. Cua, D.J. et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 : 744 748.
55. Minohara, M. et al. 2006. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J. Neuroimmunol. 178 : 156 160.
56. Kebir, H. et al. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13 : 1173 1175.
57. Su, J.-J. et al. 2006. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J. Neurol. Sci. 243 : 21 30.
58. Ryu, S. et al. 2006. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin. Rheumatol. 25 : 16 20.
59. Osoegawa, M. et al. 2004. Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis. J. Neuroimmunol. 150 : 150 156.
60. Papadopoulos, M.C. et al. 2004. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 18 : 1291 1293.
61. Manley, G.T. et al. 2006. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 6 : 159 163.